Pulmocide Receives Investment From the Cystic Fibrosis Foundation
The Cystic Fibrosis Foundation is investing $3.5 million for the development of a novel inhaled drug to prevent pulmonary aspergillosis infection in lung transplant recipients.
Category: Cystic fibrosis
Cystic fibrosis
Latest
Cystic fibrosis
Latest
Functional Respiratory Imaging and Cystic Fibrosis
Functional respiratory imaging (FRI) could lead to clinically relevant insights into the cystic fibrosis (CF) respiratory system.
Cystic fibrosis
Latest
Arrowhead Pharma Pauses Cystic Fibrosis Drug Study
The study of a cystic fibrosis treatment is on hold after a study in rats showed the drug caused lung inflammation.
Cystic Fibrosis Antisense Oligonucleotide Therapy Gets Funding Boost
The biotech company SpliSense received an investment of up to $8.4 million from the Cystic Fibrosis Foundation to develop an antisense oligonucleotide (ASO) therapy for people with cystic fibrosis who have splicing mutations.
Read More
Health Outcomes Differ Between UK and US Children With Cystic Fibrosis
A new study has confirmed that children with cystic fibrosis in the US have better lung function than UK children with the disease.
Read More
The Cellular Differences in Lungs of Cystic Fibrosis
Researchers have developed a molecular catalog of cells in healthy lungs and the lungs of people with cystic fibrosis, which could help develop new therapeutics in the future.
Read More
The Future of CRISPR for Cystic Fibrosis Just Got a Boost
The National Institutes of Health is funding a grant of more than $2 million to adapt tools that may increase the accuracy of CRISPR gene editing for cystic fibrosis.
Read More
The Benefits of Telehealth for Cystic Fibrosis Patients
A recent survey of clinicians from several cystic fibrosis centers found that cystic fibrosis care via telehealth improved efficiency and is well accepted by providers.
Read More
Wearable Device Diagnoses Cystic Fibrosis in Real Time
A team of researchers at Northwestern Engineering has developed a sticker that absorbs sweat on the skin and then changes color to provide a quick diagnosis.
Read More
Trikafta triple-combo Therapy Safe for Cystic Fibrosis Patients Ages 6-11
According to a study published in AJRCCM, Vertex Pharma’s Trikafta...
Read More
Kaftrio One Step Closer to EU Expanded Approval for Cystic Fibrosis Patients
The European Medicines Agency’s CHMP adopted a positive opinion for a label extension of Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination with ivacaftor for certain cystic fibrosis patients.
Read More
How Did the Rise of Telemedicine Change Airway Clearance Therapy for Cystic Fibrosis Patients?
For patients with cystic fibrosis, airway clearance physical therapy appointments have moved online and at-home lung function testing has become commonplace during the COVID-19 pandemic.
Read More
Cystic Fibrosis Foundation Reaffirms Support for COVID-19 Vaccination for CF Patients
The Cystic Fibrosis Foundation issued a statement encouraging people with cystic fibrosis to talk with their CF care team about getting vaccinated.
Read More
How Bacteria Can Defeat Drugs That Fight Cystic Fibrosis
Scientists have conducted new research into how bacteria defeat antibiotics in infections that are commonly seen in cystic fibrosis patients.
Read More
Kinnear Pharmaceuticals Receives Up To $3 Million to Study New Cystic Fibrosis Treatment
The Cystic Fibrosis Foundation has awarded up to $3 million to Kinnear Pharmaceuticals to conduct preclinical testing of a broad-spectrum anti-infective.
Read More